FOXA2 and type 2 diabetes mellitus: For example, this study found that most of the implicated enhancer elements were binding sites for the transcription factor FOXA2 in pancreatic islets, and previous studies have suggested that differential expression of FOXA2 is a genetic determinant of fasting glucose levels, as well as type 2 diabetes risk [29, 30].